William M Winston

发表

GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling.

Nhi N. Y. Vo, L. Poling, S. Weiler, 2010, Cancer research.

MAP3K11/GDF15 axis is a critical driver of cancer cachexia

A. Vigano, Richard Nicoletti, S. Weiler, 2015, Journal of cachexia, sarcopenia and muscle.

Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models

Richard Nicoletti, S. Weiler, J. Gyuris, 2014, Clinical Cancer Research.

Systemic RNAi in C. elegans Requires the Putative Transmembrane Protein SID-1

Craig P. Hunter, C. Hunter, William M. Winston, 2002, Science.

Systemic RNAi in Caenorhabditis elegans.

E. H. Feinberg, C. Hunter, M. Fitzgerald, 2006, Cold Spring Harbor symposia on quantitative biology.

Caenorhabditis elegans SID-2 is required for environmental RNA interference

E. H. Feinberg, C. Hunter, A. Wright, 2007, Proceedings of the National Academy of Sciences.

23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity

Richard Nicoletti, L. Poling, S. Weiler, 2015, Molecular Cancer Therapeutics.

Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibody.

D. Hicklin, G. Koelsch, H. Brodkin, 2021, Cancer treatment and research communications.

Cancer esearch apeutics , Targets , and Chemical Biology 69 , an FGFR 2-IIIb – Specific Antibody , Exhibits Potent itumor Activity against Human Cancers Driven R ctivated FGFR 2 Signaling

L. Poling, J. Gyuris, Nesreen S. Ismail, 2010 .

Abstract 2509: AV-203, a humanized ERBB3 inhibitory antibody inhibits ligand-dependent and ligand-independent ERBB3 signaling in vitro and in vivo

S. Weiler, J. Gyuris, S. Bottega, 2012 .

MAP 3 K 11 / GDF 15 axis is a critical driver of cancer cachexia

A. Vigano, Richard Nicoletti, S. Weiler, 2015 .